154 related articles for article (PubMed ID: 38416301)
1. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics.
Wei S; Gou X; Zhang Y; Cui J; Liu X; Hong N; Sheng W; Cheng J; Wang Y
Clin Exp Metastasis; 2024 Apr; 41(2):143-154. PubMed ID: 38416301
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method.
Cheng J; Wei J; Tong T; Sheng W; Zhang Y; Han Y; Gu D; Hong N; Ye Y; Tian J; Wang Y
Ann Surg Oncol; 2019 Dec; 26(13):4587-4598. PubMed ID: 31605342
[TBL] [Abstract][Full Text] [Related]
3. Identification of Predominant Histopathological Growth Patterns of Colorectal Liver Metastasis by Multi-Habitat and Multi-Sequence Based Radiomics Analysis.
Han Y; Chai F; Wei J; Yue Y; Cheng J; Gu D; Zhang Y; Tong T; Sheng W; Hong N; Ye Y; Wang Y; Tian J
Front Oncol; 2020; 10():1363. PubMed ID: 32923388
[No Abstract] [Full Text] [Related]
4. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
[TBL] [Abstract][Full Text] [Related]
5. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy.
Wei S; Han Y; Zeng H; Ye S; Cheng J; Chai F; Wei J; Zhang J; Hong N; Bao Y; Zhou J; Ye Y; Meng X; Zhou Y; Deng Y; Qiu M; Tian J; Wang Y
Eur J Radiol; 2021 Sep; 142():109863. PubMed ID: 34343846
[TBL] [Abstract][Full Text] [Related]
6. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
[TBL] [Abstract][Full Text] [Related]
7. Exploring tumor heterogeneity in colorectal liver metastases by imaging: Unsupervised machine learning of preoperative CT radiomics features for prognostic stratification.
Wang Q; Nilsson H; Xu K; Wei X; Chen D; Zhao D; Hu X; Wang A; Bai G
Eur J Radiol; 2024 Jun; 175():111459. PubMed ID: 38636408
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study.
Starmans MPA; Buisman FE; Renckens M; Willemssen FEJA; van der Voort SR; Groot Koerkamp B; Grünhagen DJ; Niessen WJ; Vermeulen PB; Verhoef C; Visser JJ; Klein S
Clin Exp Metastasis; 2021 Oct; 38(5):483-494. PubMed ID: 34533669
[TBL] [Abstract][Full Text] [Related]
10. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
Eur Radiol; 2023 Nov; ():. PubMed ID: 37987835
[TBL] [Abstract][Full Text] [Related]
11. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of MRI-based RAS mutation status prediction model for liver metastases of colorectal cancer.
Han Z; Tong Y; Zhu X; Sun D; Jia N; Feng Y; Yan K; Wei Y; He J; Ju H
J Surg Oncol; 2024 Mar; 129(3):556-567. PubMed ID: 37974474
[TBL] [Abstract][Full Text] [Related]
13. Can the computed tomography texture analysis of colorectal liver metastases predict the response to first-line cytotoxic chemotherapy?
Rabe E; Cioni D; Baglietto L; Fornili M; Gabelloni M; Neri E
World J Hepatol; 2022 Jan; 14(1):244-259. PubMed ID: 35126852
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.
Zhou Z; Han X; Sun D; Liang Z; Wu W; Ju H
Front Oncol; 2022; 12():855915. PubMed ID: 35785215
[TBL] [Abstract][Full Text] [Related]
15. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
16. Whole-liver enhanced CT radiomics analysis to predict metachronous liver metastases after rectal cancer surgery.
Liang M; Ma X; Wang L; Li D; Wang S; Zhang H; Zhao X
Cancer Imaging; 2022 Sep; 22(1):50. PubMed ID: 36089623
[TBL] [Abstract][Full Text] [Related]
17. Preoperative prediction of microsatellite instability status in colorectal cancer based on a multiphasic enhanced CT radiomics nomogram model.
Bian X; Sun Q; Wang M; Dong H; Dai X; Zhang L; Fan G; Chen G
BMC Med Imaging; 2024 Apr; 24(1):77. PubMed ID: 38566000
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
[TBL] [Abstract][Full Text] [Related]
19. Histopathological growth patterns of resected non-colorectal, non-neuroendocrine liver metastases: a retrospective multicenter study.
Meyer Y; Bohlok A; Höppener D; Galjart B; Doukas M; Grünhagen DJ; Labar A; Lucidi V; Vermeulen PB; Verhoef C; Donckier V
Clin Exp Metastasis; 2022 Jun; 39(3):433-442. PubMed ID: 35124739
[TBL] [Abstract][Full Text] [Related]
20. A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study.
Dai Y; Cheng Y; Zhou Z; Li Z; Luo Y; Qiu H
PeerJ; 2023; 11():e16230. PubMed ID: 37849829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
